Dyne Therapeutics DYN

$ 23.5 -0.63%

Quarterly report 2024-Q3
added 11-12-2024

Dyne Therapeutics Financial Statements 2011-2024 | DYN

Annual Financial Statements Dyne Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.58 B	816 M	442 M	134 M	-	-	-	-	-	-	-	2.02 B	-
Shares	61.5 M	55.6 M	51.6 M	6.92 M	-	-	-	-	-	-	-	100 M	-
Historical Prices	25.7	14.7	8.57	18.5	-	-	-	-	-	-	-	-	-
Net Income	-236 M	-168 M	-149 M	-59.4 M	-14.9 M	-4.81 M	76 M	-1.24 B	50 M	-67 M	-356 M	87 M	-1.64 B
Revenue	-	-	-	-	-	-	506 M	1.37 B	842 M	1.47 B	3 M	3 M	1.58 B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	1.91 B	2.04 B	1.84 B	321 M	321 M	3 M	622 M
Operating Income	-242 M	-171 M	-150 M	-58.6 M	-13.8 M	-	-	-	-	-	-	-	-
Interest Expense	6.22 M	2.86 M	734 K	-790 K	-1.03 M	-	-	-	-	-	-	-	-
EBITDA	-240 M	-169 M	-149 M	-57.9 M	-13.6 M	-4.77 M	455 M	126 M	678 M	-26 M	149 M	740 M	110 M
Operating Expenses	242 M	171 M	150 M	58.6 M	13.8 M	4.8 M	189 M	161 M	128 M	-308 M	97 M	-81 M	135 M
General and Administrative Expenses	31.4 M	28.2 M	28.7 M	13.4 M	2.79 M	517 K	189 M	161 M	128 M	-97 M	97 M	-22 M	135 M

All numbers in USD currency

Quarterly Income Statement Dyne Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	102 M	100 M	87.1 M	61.5 M	61.3 M	61 M	58.3 M	55.6 M	51.9 M	-	51.6 M	51.6 M	51.3 M	51.2 M	49.5 M	45.1 M	6.92 M	2.71 M	8.76 M	2.59 M	2.49 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-97.1 M	-65.1 M	-65.6 M	-	-60.2 M	-64.9 M	-44.2 M	-	-41.4 M	-52.3 M	-35.6 M	-	-42.6 M	-30 M	-25 M	-	-13.9 M	-8.98 M	-7.89 M	-	-14.9 M	-1.5 M	-2.09 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-106 M	-72 M	-69.2 M	-	-62.3 M	-66.7 M	-45.5 M	-	-42.3 M	-52.8 M	-35.8 M	-	-42.8 M	-30.2 M	-25.1 M	-	-13.5 M	-8.68 M	-7.85 M	-	-3.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	8.53 M	6.86 M	3.51 M	-	2.06 M	1.83 M	1.28 M	-	894 K	451 K	200 K	-	184 K	210 K	166 K	-	-400 K	-307 K	-33 K	-	-2.24 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-105 M	-71.6 M	-68.8 M	-	-61.9 M	-66.3 M	-45.1 M	-	-41.9 M	-52.3 M	-35.4 M	-	-42.5 M	-30 M	-24.9 M	-	-13.3 M	-8.48 M	-7.7 M	-	-3.53 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	106 M	72 M	69.2 M	-	62.3 M	66.7 M	45.5 M	-	42.3 M	52.8 M	35.8 M	-	42.8 M	30.2 M	25.1 M	-	13.5 M	8.68 M	7.85 M	-	3.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	12.9 M	9.7 M	24.6 M	-	7.02 M	7.61 M	7.93 M	-	7.61 M	6.09 M	7.55 M	-	6.26 M	6.29 M	6.51 M	-	3.84 M	1.34 M	1.76 M	-	647 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency